Educational Session 9: Management for Predisposition Gene Carriers
Session Details
The session reviewed genetic risk models, interpretation of high- and moderate-risk gene alterations, and evidence-based strategies for the clinical management of individuals with inherited cancer predisposition.
Presentation numberED9-01
Overview of genetic risk models
Tuya Pal, Vanderbilt University Medical Center, Nashville, TN
Presentation numberED9-02
Interpretation of inherited alterations in high and moderate risk genes
Fergus J Couch, Mayo Clinic, Rochester, MN
Presentation numberED9-03
Clinical management of predisposition gene carriers
Stephanie M Wong, McGill University, Montreal, QC, Canada
Advocate
Brianna Wesley-Majsiak, The Breasties Inc., Los Angeles, CA